Covid
Study: 4th Covid vaccine dose effective in protecting people over 60
As per the new Israeli-led study, the largest healthcare organisation Clalit said fourth dose of Covid vaccine is effective for protecting people aged 60 and above.
The study found that a fourth dose can reduce the possibilities of symptomatic infection, hospitalisation, serious illness and mortality among the elders, Clalit said, Xinhua news agency reported.
In the study, published in the New England Journal of Medicine, Clalit researchers and their colleagues from Harvard University in Boston analysed data from 182,122 Clalit members, all aged 60 and above, who received Pfizer’s fourth dose.
“The study unequivocally demonstrates that the fourth dose provides effective protection in preventing morbidity,” said Ran Balicer, Director of the Clalit Research Institute.
“It will help every person to make a decision on the fourth vaccine based on their level of personal risk,” he added.